MedTrace Logo

Adult-to-Adult Living Donor Transplant Cohort Study

NCT01619475 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1871

Last updated 2019-02-08

No results posted yet for this study

Summary

The study is being conducted for the following reasons:

1. To determine the prevalence, course, and predictors of poor Health Related Quality of Life (HRQOL) outcomes associated with living donor donation.
2. To collect data and biosamples prior to, during, and after a living donor liver transplant (LDLT) among all donors and recipients for use by other adult-to-adult living donor liver transplant studies and future studies.
3. To study the effects of pressure and flow on the outcomes of LDLT.
4. To characterize the differences between living donor liver transplant and deceased donor liver transplant in terms of recipient post-transplant outcomes including patient and graft survival, surgical morbidity, and resource utilization.
5. To compare the long-term histological outcomes in recipients of LDLT and deceased donor liver transplant (DDLT) with recurrent hepatitis C virus (HCV) infection.
6. To understand the history of pain management and to measure quality of care in pain control in living donors following partial hepatectomy.

Conditions

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Arbor Research Collaborative for Health

    lead OTHER

Principal Investigators

  • Robert M Merion, MD · University of Michigan

  • Averell Sherker, MD · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01619475 on ClinicalTrials.gov